Status
Conditions
Treatments
About
Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture)
(ii) Determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection)
(iii) Explore factors that could impact fecal phage carriage (patients with digestive symptoms vs. healthy individuals, immunocompromised patients vs. immunocompetent patients)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
300 participants in 2 patient groups
Loading...
Central trial contact
Cédric Hartard
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal